Chelerythrine
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Chelerythrine
Description :
Chelerythrine is a natural alkaloid, acts as a potent and selective Ca2+/phospholopid-dependent PKC antagonist, with an IC50 of 0.7 μM[1]. Chelerythrine has antitumor, antidiabetic and anti-inflammatory activity[2]. Chelerythrine inhibits the BclXL-Bak BH3 peptide binding with IC50 of 1.5 μM and displaces Bax from BclXL. Chelerythrine triggers apoptosis and autophagy[3][4].UNSPSC :
12352005Hazard Statement :
H300-H315-H319-H335Target :
Apoptosis; Autophagy; Bcl-2 Family; Beta-lactamase; PKCType :
Natural ProductsRelated Pathways :
Anti-infection; Apoptosis; Autophagy; Epigenetics; TGF-beta/SmadApplications :
Cancer-Kinase/proteaseField of Research :
Cancer; Metabolic Disease; Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/chelerythrine.htmlSolubility :
10 mM in DMSOSmiles :
C[N+]1=CC2=C(OC)C(OC)=CC=C2C(C=CC3=C4)=C1C3=CC5=C4OCO5Molecular Formula :
C21H18NO4Molecular Weight :
348.37Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Herbert JM, et al. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990 Nov 15;172 (3) :993-9.|[2]Shi B, et al. Protein kinase C inhibitor chelerythrine attenuates partial unilateral ureteral obstruction induced kidney injury in neonatal rats. Life Sci. 2019 Jan 1;216:85-91.|[3]Chan SL, et al.Identification of chelerythrine as an inhibitor of BclXL function.J Biol Chem. 2003 Jun 6;278 (23) :20453-6.|[4]Tang ZH, et al.Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells.Redox Biol. 2017 Aug;12:367-376.|[5]Li W, et al. Effect of chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway. Inflammation. 2012 Dec;35 (6) :1814-24. |[6]He N, et al. Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam. BMC Complement Altern Med. 2018 Sep 26;18 (1) :261.Shipping Conditions :
Room temperatureScientific Category :
Natural ProductsClinical Information :
No Development ReportedIsoform :
PKCCitation 01 :
Biochem Biophys Res Commun. 2024 Oct 29:739:150914.|Cancer Cell Int. 2023 Jun 17;23 (1) :117.|Cell Commun Signal. 2021 Oct 11;19 (1) :103.|FASEB J. 2019 Dec;33 (12) :13644-13659.|Fishes. 2022, 7 (5), 229.|Front Pharmacol. 2021 May 13:12:655726.|Front Physiol. 2021 Oct 28;12:770430.|Planta Med. 2024 Jun;90 (7-08) :523-533.|Bull Sib Med. 2025.|Cytokine. 2024 Jul 26:182:156717.|Harvard Medical School LINCS LIBRARY|Heliyon. 2024 Jul 28;10 (15) :e35368.|J Headache Pain. 2022 Mar 8;23 (1) :35.|J Inflamm Res. 2025 Mar 20:18:4213-4231.|Nutrients. 2025 Nov 12;17 (22) :3534.|Phytother Res. 2023 Oct;37 (10) :4674-4689.|Research Square Preprint. 2020 Oct.|Sci Rep. 2017 Aug 23;7 (1) :9201.CAS Number :
[34316-15-9]

